Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sjemmeri who wrote (2590)	9/21/2009 10:43:40 AM
From: Jibacoa	Read Replies (1) of 3722

ARNA has ben able to trim its losses in the last 2Qs The EL for the current Yr. is around $1.75 vs. the $3.24 loss in 2008 and for 2010 a further trim of the loss to around $1 is expected. The $100M credit line with Deerfield Management at 7.75% interest, which it can use for another four years, may help it to complete the data needed for the NDA on Lorcserin.<g> The results of the BLOOM PIII with > 7,000 patients look good, with no echocardiographic evidence of valvulopathy. A drug that could achieve good results on weigh loss has a wide market.<g> From a TA standpoint, the spike on Sep18 failed to pierce the resistance from the Feb19 H at the $6 level, and more important looking is the resistance from the Feb 12 H at $7.43. bigcharts.marketwatch.com On a close above that last resistance the 'target' would then be around the Nov 2007 H of $10.09 bigcharts.marketwatch.com The stock is down today 1.16% at present after a 'downgrade', with volume of > 6,344,700 which is above its ADV. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next